About Quince Therapeutics, Inc. (QNCX) data
Data as of September 30, 2026.
Quince Therapeutics, Inc. (QNCX) has 59.94K shares sold short as of the latest FINRA settlement report on September 30, 2026. Short interest has increased by 19.24% compared with the prior settlement. At the current average daily volume, covering all open short positions would take about 2.67 days (days to cover).
Frequently asked questions
What is the current short interest in QNCX?
As of the latest FINRA settlement dated September 30, 2026, QNCX had approximately 59,944 shares sold short. Short interest data is reported by FINRA twice per month.
How much does it cost to short QNCX?
The latest borrow fee (cost to borrow) for QNCX is 23.76% per year, based on IBKR data. Fees can change throughout the trading day as shares are borrowed and returned.
What is the days to cover ratio for QNCX?
Days to cover for QNCX is approximately 2.67 days. This estimates how many trading days it would take short sellers to buy back all outstanding short shares at the current average daily volume.
How many QNCX shares failed to deliver?
On September 30, 2026, the latest settlement date in the SEC's fails-to-deliver data, 1,387 shares of QNCX had failed to deliver, worth about $43.23K at the prior day's close (0.14% of shares outstanding). That is the balance still outstanding that day, not new fails. Fails come from long sales and delivery delays as well as short sales.
Is QNCX a short squeeze candidate?
A squeeze needs shorts that are hard to close. QNCX trades about 22,463 shares a day and would take roughly 2.67 days to unwind current short positions, at a current borrow fee of 23.76%. Higher days-to-cover and a rising borrow fee together are the setup to watch; neither alone is enough.